Article

Study Says Better Online Transparency Tools, Apps Could Ease Fear of Lower-Cost Healthcare

You get what you pay for: That old saw applies to most corners of American consumerism, but not to healthcare. Convincing people of that is tough.

You get what you pay for: That old saw applies to most corners of American consumerism, but not to healthcare. Convincing people of that is tough.

The research shows that most Americans believe more-expensive healthcare is usually better—an assumption that has become one major driver of unnecessary costs plaguing the U.S. healthcare system. And researchers say it will take more than just high out-of-pocket costs borne by consumers to change their views.

“People are afraid of the low-cost option because they are afraid of substandard care,” said Judith Hibbard, a senior researcher at the University of Oregon and renowned scholar on consumerism in healthcare, whose comments Tuesday came during a presentation in Chicago at the Operations and Technology Forum held by America's Health Insurance Plans.

The trick to alleviating the fear of lower-cost healthcare is to show Americans the cost of their care alongside the relevant quality rankings for potential providers they could visit. And many of the existing healthcare transparency tools could stand to improve in this regard, according to a study out Wednesday from Catalyst for Payment Reform, a not-for-profit organization that works on behalf of large employers and other healthcare purchasers.

Read the full story here: http://bit.ly/1aINrOv

Source: Modern Healthcare

Related Videos
Crystal S. Denlinger, MD, FACP, CEO of the National Comprehensive Cancer Network
Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
Nancy Dreyer, MPH, PhD, FISE, chief scientific advisor to Picnic Health
Seth Berkowitz, MD, MPH, associate professor of medicine, University of North Carolina at Chapel Hill
Inma Hernandez, PharmD, PhD, professor at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences
Dr Julie Patterson, National Pharmaceutical Council
Related Content
CH LogoCenter for Biosimilars Logo